Publications by authors named "Udo Oppermann"

Claim this Profile
A
ATF4-mediated stress response as a therapeutic vulnerability in chordoma.
Lucia Cottone, James Dunford, Eleanor Calcutt, Vicki Gamble, Filiz Senbabaoglu Aksu, Udo Oppermann

Mol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia.
Simge Kelekçi, Katherine Kelly, Ashish Goyal, Nick Wehrwein, Anna Riedel, Udo Oppermann

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic Dissection of the Reaction of Human GDP-l-Fucose Synthase.
Denis Smyshliaev, Martin Pfeiffer, Udo Oppermann, Bernd Nidetzky

ACS Catal· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding.
Chen-Yi Wang, Martin Philpott, Darragh P O'Brien, Anne Ndungu, Jessica Malzahn, Udo Oppermann

Commun Med (Lond)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belantamab Mafodotin Monotherapy for Multiply-Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of Ireland.
Edmund C R Watson, Faouzi Djebbari, Fotios Panitsas, Grant Vallance, Samir Asher, Udo Oppermann

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.
Ozlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz, Ali Cenk Aksu, Beril Esin, Udo Oppermann

Exp Mol Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing single-cell transcriptomics using interposed anchor oligonucleotide sequences.
Jianfeng Sun, Martin Philpott, Danson Loi, Gabriela Hoffman, Jonathan Robson, Udo Oppermann

Commun Biol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human milk oligosaccharide 3'sialyllactose reduces low-grade inflammation and atherosclerosis development in mice.
Ariane R Pessentheiner, Nathanael J Spann, Chloe A Autran, Tae Gyu Oh, Kaare V Grunddal, Udo Oppermann

JCI Insight· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.
Gaurav Agarwal, Sally Moore, Ross Sadler, Sherin Varghese, Alison Turner, Udo Oppermann

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma.
Oliver Van Oekelen, Michael Amatangelo, Manman Guo, Bhaskar Upadhyaya, Adam P Cribbs, Udo Oppermann

Cell Rep Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.
Clement Twumasi, Sally Moore, Ross Sadler, Sally Jeans, Sherin Varghese, Udo Oppermann

Eur J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.
Yan Xiong, Holger Greschik, Catrine Johansson, Ludwig Seifert, Vicki Gamble, Udo Oppermann

J Med Chem· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms.
Chao-Hui Chang, Feng Liu, Stefania Militi, Svenja Hester, Reshma Nibhani, Udo Oppermann

Nat Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correcting PCR amplification errors in unique molecular identifiers to generate accurate numbers of sequencing molecules.
Jianfeng Sun, Martin Philpott, Danson Loi, Shuang Li, Pablo Monteagudo-Mesas, Udo Oppermann

Nat Methods· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.
Yuliang Feng, Liuyang Cai, Martin Pook, Feng Liu, Chao-Hui Chang, Udo Oppermann

Gastroenterology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo.
Elizabeth J Brown, Leire Balaguer-Lluna, Adam P Cribbs, Martin Philpott, Leticia Campo, Udo Oppermann

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass cytometry as a tool in target validation and drug discovery.
Edmund C R Watson, Warren Baker, David Ahern, Danson Loi, Adam P Cribbs, Udo Oppermann

Methods Enzymol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics.
Mai Abdel Mouti, Siwei Deng, Martin Pook, Jessica Malzahn, Aniko Rendek, Udo Oppermann

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Chemical Screening in CD4 T Cells to Identify Epigenetic Inhibitors.
Adam P Cribbs, Udo Oppermann

Methods Mol Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSD3B1 is an oxysterol 3β-hydroxysteroid dehydrogenase in human placenta.
Alison Dickson, Eylan Yutuc, Catherine A Thornton, James E Dunford, Udo Oppermann

Open Biol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2.
Zachary W Davis-Gilbert, Andreas Krämer, James E Dunford, Stefanie Howell, Filiz Senbabaoglu, Udo Oppermann

ACS Med Chem Lett· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma.
Yuliang Feng, Liuyang Cai, Martin Pook, Feng Liu, Chao-Hui Chang, Udo Oppermann

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Keiji Kurata, Anna James-Bott, Mark A Tye, Leona Yamamoto, Mehmet K Samur, Udo Oppermann

Blood Cancer J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Read Single-Cell Sequencing Using scCOLOR-seq.
Martin Philpott, Udo Oppermann, Adam P Cribbs

Methods Mol Biol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Keiji Kurata, Anna James-Bott, Mark A Tye, Leona Yamamoto, Mehmet K Samur, Udo Oppermann

Blood Cancer J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis